What is HAE's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 5.40B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for HAE?

P/E (TTM) is 56.17 and 52-week range is $48.17 to $121.00 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s HAE figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for HAE?

The company profile lists revenue (TTM) near $1.34B, net income (TTM) near $96M, EPS (TTM) near $2.05 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Haemonetics Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Boston, Massachusetts, US, 45.5M shares outstanding, ISIN US4050241003 when available from company profile and filing metadata.

Haemonetics Corp

$HAE

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$118.69

-0.65%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.

Employees

3,023

Website

www.haemonetics.com

IPO

1979-10-17

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)